AMAG Pharmaceuticals Just Filed Its Quarterly Report: The components of b...


The components of basic and diluted net loss per share were as follows (in thousands, except per share data):

 

 

 

Three Months Ended March 31,

 

 

 

2014

 

2013

 

Net loss

 

$

(7,102

)

$

(3,895

)

Weighted average common shares outstanding

 

21,824

 

21,544

 

Net loss per share:

 

 

 

 

 

Basic and diluted

 

$

(0.33

)

$

(0.18

)

 

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

SVP of AMAG Pharmaceuticals just disposed of 859 shares - Dec. 18, 2014
SVP of AMAG Pharmaceuticals just disposed of 1,789 shares - Dec. 18, 2014
EVP of AMAG Pharmaceuticals just disposed of 7,046 shares - Dec. 18, 2014
AMAG Pharmaceuticals's President and CEO just disposed of 9,890 shares - Dec. 18, 2014
AMAG: Departures Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers - Dec. 11, 2014

   Auto Refresh

Feedback